Familial Hypercholesterolemia and Lipoprotein Apheresis

Lipoprotein apheresis has been developed as the treatment for refractory familial hypercholesterolemia (FH) to remove low-density lipoprotein (LDL), which is the main pathogenic factor. Currently, three procedures are available in Japan, including the plasma exchange, double-membrane filtration, and...

Full description

Saved in:
Bibliographic Details
Published in:J Atheroscler Thromb
Main Authors: Makino, Hisashi, Koezuka, Ryo, Tamanaha, Tamiko, Ogura, Masatsune, Matsuki, Kota, Hosoda, Kiminori, Harada-Shiba, Mariko
Format: Artigo
Language:Inglês
Published: Japan Atherosclerosis Society 2019
Subjects:
Review
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6711846/
https://ncbi.nlm.nih.gov/pubmed/31231083
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5551/jat.RV17033
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items